A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
WRNIP1
|
ENSG00000124535.11 | WRN helicase interacting protein 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
WRNIP1 | hg19_v2_chr6_+_2765595_2765797 | -0.21 | 7.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_60719213 | 1.86 |
ENST00000227880.3
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3 |
chr11_+_57310114 | 1.52 |
ENST00000527972.1
ENST00000399154.2 |
SMTNL1
|
smoothelin-like 1 |
chr6_+_29691056 | 1.42 |
ENST00000414333.1
ENST00000334668.4 ENST00000259951.7 |
HLA-F
|
major histocompatibility complex, class I, F |
chr12_-_121477039 | 1.29 |
ENST00000257570.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr19_-_47128294 | 1.28 |
ENST00000596260.1
ENST00000597185.1 ENST00000598865.1 ENST00000594275.1 ENST00000291294.2 |
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP) |
chr15_+_89182156 | 1.27 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr12_-_121476959 | 1.24 |
ENST00000339275.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr19_+_39786962 | 1.21 |
ENST00000333625.2
|
IFNL1
|
interferon, lambda 1 |
chr19_-_49371711 | 1.18 |
ENST00000355496.5
ENST00000263265.6 |
PLEKHA4
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 |
chr19_+_51152702 | 1.05 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
chr19_-_49362621 | 1.04 |
ENST00000594195.1
ENST00000595867.1 |
PLEKHA4
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 |
chr11_+_5710919 | 1.03 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr15_+_89182178 | 1.03 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr2_-_231090344 | 0.99 |
ENST00000540870.1
ENST00000416610.1 |
SP110
|
SP110 nuclear body protein |
chr20_-_62203808 | 0.98 |
ENST00000467148.1
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator |
chr12_+_113416191 | 0.97 |
ENST00000342315.4
ENST00000392583.2 |
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr12_-_121476750 | 0.96 |
ENST00000543677.1
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr19_+_51153045 | 0.95 |
ENST00000458538.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
chr8_-_23261589 | 0.95 |
ENST00000524168.1
ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2
|
lysyl oxidase-like 2 |
chr1_+_948803 | 0.95 |
ENST00000379389.4
|
ISG15
|
ISG15 ubiquitin-like modifier |
chr19_+_16254488 | 0.95 |
ENST00000588246.1
ENST00000593031.1 |
HSH2D
|
hematopoietic SH2 domain containing |
chr19_-_10213335 | 0.94 |
ENST00000592641.1
ENST00000253109.4 |
ANGPTL6
|
angiopoietin-like 6 |
chr6_+_32812568 | 0.91 |
ENST00000414474.1
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr15_-_40401062 | 0.88 |
ENST00000354670.4
ENST00000559701.1 ENST00000557870.1 ENST00000558774.1 |
BMF
|
Bcl2 modifying factor |
chr19_+_18723660 | 0.88 |
ENST00000262817.3
|
TMEM59L
|
transmembrane protein 59-like |
chr6_+_29691198 | 0.86 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
chr2_+_218933972 | 0.85 |
ENST00000374155.3
|
RUFY4
|
RUN and FYVE domain containing 4 |
chr19_+_54412517 | 0.84 |
ENST00000391767.1
|
CACNG7
|
calcium channel, voltage-dependent, gamma subunit 7 |
chr19_-_51845378 | 0.83 |
ENST00000335624.4
|
VSIG10L
|
V-set and immunoglobulin domain containing 10 like |
chr16_+_56642041 | 0.83 |
ENST00000245185.5
|
MT2A
|
metallothionein 2A |
chr22_-_24622080 | 0.83 |
ENST00000425408.1
|
GGT5
|
gamma-glutamyltransferase 5 |
chr6_+_32811885 | 0.81 |
ENST00000458296.1
ENST00000413039.1 ENST00000429600.1 ENST00000412095.1 ENST00000415067.1 ENST00000395330.1 |
TAPSAR1
PSMB9
|
TAP1 and PSMB8 antisense RNA 1 proteasome (prosome, macropain) subunit, beta type, 9 |
chr15_+_90744745 | 0.79 |
ENST00000558051.1
|
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
chr6_-_32820529 | 0.77 |
ENST00000425148.2
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr15_+_89181974 | 0.77 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr19_-_36019123 | 0.76 |
ENST00000588674.1
ENST00000452271.2 ENST00000518157.1 |
SBSN
|
suprabasin |
chr1_+_223354486 | 0.75 |
ENST00000446145.1
|
RP11-239E10.3
|
RP11-239E10.3 |
chr15_+_41221536 | 0.74 |
ENST00000249749.5
|
DLL4
|
delta-like 4 (Drosophila) |
chr19_-_55881741 | 0.74 |
ENST00000264563.2
ENST00000590625.1 ENST00000585513.1 |
IL11
|
interleukin 11 |
chr19_+_10197463 | 0.73 |
ENST00000590378.1
ENST00000397881.3 |
C19orf66
|
chromosome 19 open reading frame 66 |
chr2_-_42160486 | 0.72 |
ENST00000427054.1
|
AC104654.2
|
AC104654.2 |
chr2_-_231084820 | 0.71 |
ENST00000258382.5
ENST00000338556.3 |
SP110
|
SP110 nuclear body protein |
chr2_+_121493717 | 0.70 |
ENST00000418323.1
|
GLI2
|
GLI family zinc finger 2 |
chr11_+_69455855 | 0.70 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
chr11_+_5711010 | 0.70 |
ENST00000454828.1
|
TRIM22
|
tripartite motif containing 22 |
chr8_-_145060593 | 0.70 |
ENST00000313059.5
ENST00000524918.1 ENST00000313028.7 ENST00000525773.1 |
PARP10
|
poly (ADP-ribose) polymerase family, member 10 |
chr11_-_615570 | 0.69 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr19_+_35532612 | 0.69 |
ENST00000600390.1
ENST00000597419.1 |
HPN
|
hepsin |
chr12_-_116714564 | 0.69 |
ENST00000548743.1
|
MED13L
|
mediator complex subunit 13-like |
chr19_-_51289374 | 0.69 |
ENST00000563228.1
|
CTD-2568A17.1
|
CTD-2568A17.1 |
chr13_+_114462193 | 0.68 |
ENST00000375353.3
|
TMEM255B
|
transmembrane protein 255B |
chr6_+_32821924 | 0.67 |
ENST00000374859.2
ENST00000453265.2 |
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr14_-_77542485 | 0.67 |
ENST00000556781.1
ENST00000557526.1 ENST00000555512.1 |
RP11-7F17.3
|
RP11-7F17.3 |
chr19_-_19051993 | 0.66 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr14_-_67859422 | 0.65 |
ENST00000556532.1
|
PLEK2
|
pleckstrin 2 |
chr19_-_19051927 | 0.65 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
chr17_-_8027402 | 0.65 |
ENST00000541682.2
ENST00000317814.4 ENST00000577735.1 |
HES7
|
hes family bHLH transcription factor 7 |
chr16_+_57023406 | 0.65 |
ENST00000262510.6
ENST00000308149.7 ENST00000436936.1 |
NLRC5
|
NLR family, CARD domain containing 5 |
chr14_-_94443105 | 0.65 |
ENST00000555019.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
chr17_-_34417479 | 0.65 |
ENST00000225245.5
|
CCL3
|
chemokine (C-C motif) ligand 3 |
chr19_+_51226648 | 0.64 |
ENST00000599973.1
|
CLEC11A
|
C-type lectin domain family 11, member A |
chr7_-_93519471 | 0.64 |
ENST00000451238.1
|
TFPI2
|
tissue factor pathway inhibitor 2 |
chr7_-_41740181 | 0.63 |
ENST00000442711.1
|
INHBA
|
inhibin, beta A |
chr16_-_11350036 | 0.63 |
ENST00000332029.2
|
SOCS1
|
suppressor of cytokine signaling 1 |
chr11_+_57308979 | 0.62 |
ENST00000457912.1
|
SMTNL1
|
smoothelin-like 1 |
chr11_-_4414880 | 0.62 |
ENST00000254436.7
ENST00000543625.1 |
TRIM21
|
tripartite motif containing 21 |
chr1_+_3689325 | 0.62 |
ENST00000444870.2
ENST00000452264.1 |
SMIM1
|
small integral membrane protein 1 (Vel blood group) |
chr5_-_176923803 | 0.62 |
ENST00000506161.1
|
PDLIM7
|
PDZ and LIM domain 7 (enigma) |
chr19_-_31840130 | 0.62 |
ENST00000558569.1
|
TSHZ3
|
teashirt zinc finger homeobox 3 |
chr11_-_321050 | 0.62 |
ENST00000399808.4
|
IFITM3
|
interferon induced transmembrane protein 3 |
chr11_+_12108410 | 0.61 |
ENST00000527997.1
|
RP13-631K18.5
|
RP13-631K18.5 |
chr6_+_32811861 | 0.61 |
ENST00000453426.1
|
TAPSAR1
|
TAP1 and PSMB8 antisense RNA 1 |
chr12_+_113344755 | 0.61 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr6_-_32821599 | 0.61 |
ENST00000354258.4
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr19_+_6887571 | 0.60 |
ENST00000250572.8
ENST00000381407.5 ENST00000312053.4 ENST00000450315.3 ENST00000381404.4 |
EMR1
|
egf-like module containing, mucin-like, hormone receptor-like 1 |
chr17_-_42988004 | 0.60 |
ENST00000586125.1
ENST00000591880.1 |
GFAP
|
glial fibrillary acidic protein |
chr16_+_57438679 | 0.60 |
ENST00000219244.4
|
CCL17
|
chemokine (C-C motif) ligand 17 |
chr17_-_39677971 | 0.59 |
ENST00000393976.2
|
KRT15
|
keratin 15 |
chr19_-_47220335 | 0.59 |
ENST00000601806.1
ENST00000593363.1 ENST00000598633.1 ENST00000595515.1 ENST00000433867.1 |
PRKD2
|
protein kinase D2 |
chr6_-_35888858 | 0.58 |
ENST00000507909.1
|
SRPK1
|
SRSF protein kinase 1 |
chr10_+_91152303 | 0.58 |
ENST00000371804.3
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr7_+_100770328 | 0.58 |
ENST00000223095.4
ENST00000445463.2 |
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
chr19_+_49661079 | 0.58 |
ENST00000355712.5
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4 |
chr19_+_35521699 | 0.57 |
ENST00000415950.3
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr2_+_8822113 | 0.57 |
ENST00000396290.1
ENST00000331129.3 |
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
chr19_-_1155118 | 0.57 |
ENST00000590998.1
|
SBNO2
|
strawberry notch homolog 2 (Drosophila) |
chr6_+_31465849 | 0.57 |
ENST00000399150.3
|
MICB
|
MHC class I polypeptide-related sequence B |
chr16_-_85784734 | 0.57 |
ENST00000602719.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
chr4_+_81118647 | 0.57 |
ENST00000415738.2
|
PRDM8
|
PR domain containing 8 |
chr11_-_64764435 | 0.57 |
ENST00000534177.1
ENST00000301887.4 |
BATF2
|
basic leucine zipper transcription factor, ATF-like 2 |
chr2_+_210288760 | 0.57 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
chr19_+_41119323 | 0.57 |
ENST00000599724.1
ENST00000597071.1 ENST00000243562.9 |
LTBP4
|
latent transforming growth factor beta binding protein 4 |
chr19_-_51504852 | 0.56 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
chr5_-_176923846 | 0.56 |
ENST00000506537.1
|
PDLIM7
|
PDZ and LIM domain 7 (enigma) |
chr22_-_24641027 | 0.56 |
ENST00000398292.3
ENST00000263112.7 ENST00000418439.2 ENST00000424217.1 ENST00000327365.4 |
GGT5
|
gamma-glutamyltransferase 5 |
chr19_-_36004543 | 0.56 |
ENST00000339686.3
ENST00000447113.2 ENST00000440396.1 |
DMKN
|
dermokine |
chr22_+_36649056 | 0.56 |
ENST00000397278.3
ENST00000422706.1 ENST00000426053.1 ENST00000319136.4 |
APOL1
|
apolipoprotein L, 1 |
chr7_-_139756791 | 0.56 |
ENST00000489809.1
|
PARP12
|
poly (ADP-ribose) polymerase family, member 12 |
chr14_+_23352374 | 0.56 |
ENST00000267396.4
ENST00000536884.1 |
REM2
|
RAS (RAD and GEM)-like GTP binding 2 |
chr5_-_176924562 | 0.56 |
ENST00000359895.2
ENST00000355572.2 ENST00000355841.2 ENST00000393551.1 ENST00000505074.1 ENST00000356618.4 ENST00000393546.4 |
PDLIM7
|
PDZ and LIM domain 7 (enigma) |
chr14_-_24616426 | 0.55 |
ENST00000216802.5
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
chr19_+_45542773 | 0.55 |
ENST00000544944.2
|
CLASRP
|
CLK4-associating serine/arginine rich protein |
chr9_-_96717654 | 0.55 |
ENST00000253968.6
|
BARX1
|
BARX homeobox 1 |
chr19_+_49661037 | 0.55 |
ENST00000427978.2
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4 |
chr6_-_31324943 | 0.55 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr5_-_172756506 | 0.55 |
ENST00000265087.4
|
STC2
|
stanniocalcin 2 |
chrX_-_106146547 | 0.55 |
ENST00000276173.4
ENST00000411805.1 |
RIPPLY1
|
ripply transcriptional repressor 1 |
chr2_-_219850277 | 0.54 |
ENST00000295727.1
|
FEV
|
FEV (ETS oncogene family) |
chr9_-_34628104 | 0.54 |
ENST00000378909.2
|
ARID3C
|
AT rich interactive domain 3C (BRIGHT-like) |
chr15_+_74466012 | 0.54 |
ENST00000249842.3
|
ISLR
|
immunoglobulin superfamily containing leucine-rich repeat |
chr19_+_54466179 | 0.54 |
ENST00000270458.2
|
CACNG8
|
calcium channel, voltage-dependent, gamma subunit 8 |
chr5_-_150466692 | 0.54 |
ENST00000315050.7
ENST00000523338.1 ENST00000522100.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
chr12_-_113658892 | 0.54 |
ENST00000299732.2
ENST00000416617.2 |
IQCD
|
IQ motif containing D |
chr19_-_51875894 | 0.54 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr7_+_114562616 | 0.54 |
ENST00000448022.1
|
MDFIC
|
MyoD family inhibitor domain containing |
chr12_-_7245018 | 0.54 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
chr20_-_44540686 | 0.53 |
ENST00000477313.1
ENST00000542937.1 ENST00000372431.3 ENST00000354050.4 ENST00000420868.2 |
PLTP
|
phospholipid transfer protein |
chr11_+_123301012 | 0.53 |
ENST00000533341.1
|
AP000783.1
|
Uncharacterized protein |
chr7_-_134143841 | 0.53 |
ENST00000285930.4
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase) |
chr20_-_44455976 | 0.53 |
ENST00000372555.3
|
TNNC2
|
troponin C type 2 (fast) |
chr8_-_141645645 | 0.53 |
ENST00000519980.1
ENST00000220592.5 |
AGO2
|
argonaute RISC catalytic component 2 |
chr17_+_38171681 | 0.53 |
ENST00000225474.2
ENST00000331769.2 ENST00000394148.3 ENST00000577675.1 |
CSF3
|
colony stimulating factor 3 (granulocyte) |
chr15_+_90744533 | 0.53 |
ENST00000411539.2
|
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
chr2_+_220306745 | 0.53 |
ENST00000431523.1
ENST00000396698.1 ENST00000396695.2 |
SPEG
|
SPEG complex locus |
chr11_-_33891362 | 0.52 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr19_+_48898132 | 0.52 |
ENST00000263269.3
|
GRIN2D
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
chrX_-_153141302 | 0.52 |
ENST00000361699.4
ENST00000543994.1 ENST00000370057.3 ENST00000538883.1 ENST00000361981.3 |
L1CAM
|
L1 cell adhesion molecule |
chr11_-_102668879 | 0.52 |
ENST00000315274.6
|
MMP1
|
matrix metallopeptidase 1 (interstitial collagenase) |
chr12_+_113344582 | 0.52 |
ENST00000202917.5
ENST00000445409.2 ENST00000452357.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr19_+_45504688 | 0.51 |
ENST00000221452.8
ENST00000540120.1 ENST00000505236.1 |
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B |
chr7_-_75443118 | 0.51 |
ENST00000222902.2
|
CCL24
|
chemokine (C-C motif) ligand 24 |
chr14_+_103058948 | 0.51 |
ENST00000262241.6
|
RCOR1
|
REST corepressor 1 |
chr12_+_113344811 | 0.51 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr17_+_74380683 | 0.51 |
ENST00000592299.1
ENST00000590959.1 ENST00000323374.4 |
SPHK1
|
sphingosine kinase 1 |
chr10_+_91087651 | 0.51 |
ENST00000371818.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr17_-_34207295 | 0.51 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
chr11_-_104905840 | 0.51 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
chr12_+_13044787 | 0.50 |
ENST00000534831.1
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A |
chr19_+_38826477 | 0.50 |
ENST00000409410.2
ENST00000215069.4 |
CATSPERG
|
catsper channel auxiliary subunit gamma |
chr12_+_52668394 | 0.50 |
ENST00000423955.2
|
KRT86
|
keratin 86 |
chr3_-_122283424 | 0.50 |
ENST00000477522.2
ENST00000360356.2 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr1_-_27998689 | 0.50 |
ENST00000339145.4
ENST00000362020.4 ENST00000361157.6 |
IFI6
|
interferon, alpha-inducible protein 6 |
chr11_-_44331679 | 0.50 |
ENST00000329255.3
|
ALX4
|
ALX homeobox 4 |
chr12_+_2912363 | 0.50 |
ENST00000544366.1
|
FKBP4
|
FK506 binding protein 4, 59kDa |
chr3_-_122283100 | 0.50 |
ENST00000492382.1
ENST00000462315.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr2_+_45168875 | 0.50 |
ENST00000260653.3
|
SIX3
|
SIX homeobox 3 |
chr7_+_45927956 | 0.50 |
ENST00000275525.3
ENST00000457280.1 |
IGFBP1
|
insulin-like growth factor binding protein 1 |
chr22_+_36649170 | 0.49 |
ENST00000438034.1
ENST00000427990.1 ENST00000347595.7 ENST00000397279.4 ENST00000433768.1 ENST00000440669.2 |
APOL1
|
apolipoprotein L, 1 |
chr19_+_49660997 | 0.49 |
ENST00000598691.1
ENST00000252826.5 |
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4 |
chr19_+_41119794 | 0.49 |
ENST00000593463.1
|
LTBP4
|
latent transforming growth factor beta binding protein 4 |
chr19_-_39735646 | 0.49 |
ENST00000413851.2
|
IFNL3
|
interferon, lambda 3 |
chr7_+_69064566 | 0.49 |
ENST00000403018.2
|
AUTS2
|
autism susceptibility candidate 2 |
chr12_+_52626898 | 0.49 |
ENST00000331817.5
|
KRT7
|
keratin 7 |
chr19_+_39759154 | 0.49 |
ENST00000331982.5
|
IFNL2
|
interferon, lambda 2 |
chr10_-_79397740 | 0.49 |
ENST00000372440.1
ENST00000480683.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr22_-_50964849 | 0.48 |
ENST00000543927.1
ENST00000423348.1 |
SCO2
|
SCO2 cytochrome c oxidase assembly protein |
chrX_+_48367338 | 0.48 |
ENST00000359882.4
ENST00000537758.1 ENST00000367574.4 ENST00000355961.4 ENST00000489940.1 ENST00000361988.3 |
PORCN
|
porcupine homolog (Drosophila) |
chr12_+_113416265 | 0.48 |
ENST00000449768.2
|
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr12_+_113354341 | 0.48 |
ENST00000553152.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chrX_+_56259316 | 0.48 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
chr11_+_130184888 | 0.48 |
ENST00000602376.1
ENST00000532116.3 ENST00000602310.1 |
RP11-121M22.1
|
RP11-121M22.1 |
chr18_-_19748331 | 0.48 |
ENST00000584201.1
|
GATA6-AS1
|
GATA6 antisense RNA 1 (head to head) |
chr10_-_10504285 | 0.48 |
ENST00000602311.1
|
RP11-271F18.4
|
RP11-271F18.4 |
chr19_-_8642289 | 0.48 |
ENST00000596675.1
ENST00000338257.8 |
MYO1F
|
myosin IF |
chr15_-_74284558 | 0.48 |
ENST00000359750.4
ENST00000541638.1 ENST00000562453.1 |
STOML1
|
stomatin (EPB72)-like 1 |
chr2_-_231084659 | 0.48 |
ENST00000258381.6
ENST00000358662.4 ENST00000455674.1 ENST00000392048.3 |
SP110
|
SP110 nuclear body protein |
chr12_-_113658826 | 0.48 |
ENST00000546692.1
|
IQCD
|
IQ motif containing D |
chr2_-_191885686 | 0.48 |
ENST00000432058.1
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
chr3_-_88108212 | 0.48 |
ENST00000482016.1
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
chr5_-_172755056 | 0.48 |
ENST00000520648.1
|
STC2
|
stanniocalcin 2 |
chr19_+_18718214 | 0.47 |
ENST00000600490.1
|
TMEM59L
|
transmembrane protein 59-like |
chr6_+_17393888 | 0.47 |
ENST00000493172.1
ENST00000465994.1 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr19_-_44172396 | 0.47 |
ENST00000602141.1
ENST00000593939.1 ENST00000599546.1 |
PLAUR
|
plasminogen activator, urokinase receptor |
chr20_-_4804244 | 0.47 |
ENST00000379400.3
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr3_-_122283079 | 0.47 |
ENST00000471785.1
ENST00000466126.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr8_-_145086922 | 0.47 |
ENST00000530478.1
|
PARP10
|
poly (ADP-ribose) polymerase family, member 10 |
chrX_-_70326455 | 0.47 |
ENST00000374251.5
|
CXorf65
|
chromosome X open reading frame 65 |
chr3_-_124839648 | 0.47 |
ENST00000430155.2
|
SLC12A8
|
solute carrier family 12, member 8 |
chr5_-_168727786 | 0.46 |
ENST00000332966.8
|
SLIT3
|
slit homolog 3 (Drosophila) |
chr1_-_153521714 | 0.46 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
chr11_+_118826999 | 0.46 |
ENST00000264031.2
|
UPK2
|
uroplakin 2 |
chr20_+_4129496 | 0.46 |
ENST00000346595.2
|
SMOX
|
spermine oxidase |
chr16_-_84651673 | 0.46 |
ENST00000262428.4
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chr2_-_217236750 | 0.46 |
ENST00000273067.4
|
MARCH4
|
membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase |
chr11_-_64512273 | 0.46 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr3_+_38179969 | 0.46 |
ENST00000396334.3
ENST00000417037.2 ENST00000424893.1 ENST00000495303.1 ENST00000443433.2 ENST00000421516.1 |
MYD88
|
myeloid differentiation primary response 88 |
chr19_-_46272462 | 0.46 |
ENST00000317578.6
|
SIX5
|
SIX homeobox 5 |
chr3_-_157823839 | 0.46 |
ENST00000425436.3
ENST00000389589.4 ENST00000441443.2 |
SHOX2
|
short stature homeobox 2 |
chr8_-_61193947 | 0.45 |
ENST00000317995.4
|
CA8
|
carbonic anhydrase VIII |
chr14_-_98444386 | 0.45 |
ENST00000556462.1
ENST00000556138.1 |
C14orf64
|
chromosome 14 open reading frame 64 |
chr17_+_77018896 | 0.45 |
ENST00000578229.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr12_+_75874984 | 0.45 |
ENST00000550491.1
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr18_-_19748379 | 0.44 |
ENST00000579431.1
|
GATA6-AS1
|
GATA6 antisense RNA 1 (head to head) |
chr1_-_11918988 | 0.44 |
ENST00000376468.3
|
NPPB
|
natriuretic peptide B |
chr1_-_28503693 | 0.44 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
chr12_+_121088291 | 0.44 |
ENST00000351200.2
|
CABP1
|
calcium binding protein 1 |
chr14_-_50474238 | 0.44 |
ENST00000399206.1
|
C14orf182
|
chromosome 14 open reading frame 182 |
chr18_+_70536215 | 0.44 |
ENST00000578967.1
|
RP11-676J15.1
|
RP11-676J15.1 |
chr6_-_31926629 | 0.44 |
ENST00000375425.5
ENST00000426722.1 ENST00000441998.1 ENST00000444811.2 ENST00000375429.3 |
NELFE
|
negative elongation factor complex member E |
chr12_+_112451222 | 0.43 |
ENST00000552052.1
|
ERP29
|
endoplasmic reticulum protein 29 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.5 | 1.9 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.5 | 1.8 | GO:1904199 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.4 | 3.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.4 | 1.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 1.4 | GO:0018277 | protein deamination(GO:0018277) |
0.3 | 1.3 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.3 | 1.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.3 | 0.6 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.3 | 0.9 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.3 | 1.2 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.3 | 1.4 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.3 | 2.2 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.3 | 0.8 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.3 | 0.8 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.3 | 0.8 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
0.3 | 0.3 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.3 | 1.5 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.3 | 2.8 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 0.7 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 1.2 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.2 | 0.2 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.2 | 1.1 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 0.9 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 0.9 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.9 | GO:0070846 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.2 | 1.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.8 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 1.2 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.2 | 1.5 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 0.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 0.6 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.2 | 0.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.7 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.2 | 0.5 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.2 | 0.5 | GO:1904303 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.2 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 0.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 0.7 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.2 | 0.3 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.2 | 0.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
0.2 | 0.2 | GO:0032423 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
0.2 | 0.5 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.2 | 0.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 0.5 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.2 | 1.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 1.1 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 1.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 0.5 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.2 | 0.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.9 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.8 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.2 | 0.5 | GO:0035572 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.2 | 0.2 | GO:0060067 | cervix development(GO:0060067) |
0.2 | 1.8 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.2 | 0.5 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.2 | 1.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.5 | GO:0019082 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.1 | 0.6 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.1 | 2.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.9 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 1.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.6 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 1.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.3 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.1 | 0.4 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 0.7 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.4 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.4 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.4 | GO:0045360 | interleukin-1 biosynthetic process(GO:0042222) regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.1 | 2.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.6 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 0.7 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 1.4 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.1 | 1.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.4 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.1 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.4 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 | 0.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.4 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.1 | 0.5 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.1 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.1 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.4 | GO:2000625 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.1 | 0.5 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.1 | 0.6 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.1 | 0.4 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.1 | 0.5 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.1 | 0.5 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.1 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.1 | 0.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.5 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.1 | 0.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 0.4 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.1 | 0.4 | GO:0043311 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 0.4 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
0.1 | 1.1 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 1.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.9 | GO:2000784 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.1 | 1.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.1 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.1 | 13.0 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.8 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.2 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.1 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
0.1 | 0.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.6 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 | 0.5 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 0.1 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.1 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.3 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.1 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 1.1 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 1.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.4 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.3 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 0.2 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.3 | GO:1902203 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
0.1 | 0.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.3 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 0.8 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 1.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.1 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.1 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.3 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.1 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.3 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.5 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.1 | 0.3 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 0.3 | GO:0090260 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.1 | 0.2 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.1 | 0.3 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.1 | 0.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.3 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.1 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.5 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.4 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.4 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.1 | 0.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 1.9 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.1 | 0.2 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.1 | 0.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 0.4 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.1 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.1 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.1 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.1 | 0.1 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
0.1 | 0.2 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.1 | 0.4 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.1 | 1.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
0.1 | 0.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) regulation of skeletal muscle hypertrophy(GO:1904204) |
0.1 | 0.3 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.1 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.8 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 1.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.7 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.4 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.1 | 0.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 0.3 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
0.1 | 0.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 1.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.9 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 2.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.3 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.1 | 0.3 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.1 | 0.3 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.1 | 0.3 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
0.1 | 0.3 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.1 | 0.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.1 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.3 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 0.1 | GO:0090402 | senescence-associated heterochromatin focus assembly(GO:0035986) oncogene-induced cell senescence(GO:0090402) |
0.1 | 0.6 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 0.1 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.1 | 1.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.3 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.1 | 0.3 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.1 | 0.2 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.1 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 1.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.3 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 3.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.1 | GO:0060577 | pulmonary vein morphogenesis(GO:0060577) |
0.1 | 0.2 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.1 | 0.6 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
0.1 | 0.6 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.1 | 0.9 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.6 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.5 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
0.1 | 0.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.3 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
0.1 | 0.3 | GO:0050705 | negative regulation of interleukin-1 alpha production(GO:0032690) regulation of interleukin-1 alpha secretion(GO:0050705) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.1 | 0.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.4 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.2 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.1 | 0.3 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.1 | 0.8 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.2 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.2 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.1 | 0.2 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 0.8 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.4 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.2 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.1 | 0.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.1 | 0.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.1 | 0.2 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.1 | 0.2 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.1 | 0.5 | GO:0097168 | transforming growth factor beta activation(GO:0036363) mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 0.2 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.1 | 0.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.4 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.1 | 0.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 0.2 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.1 | 0.1 | GO:0060066 | oviduct development(GO:0060066) |
0.1 | 0.9 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 0.2 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.1 | 0.2 | GO:0002818 | intracellular defense response(GO:0002818) |
0.1 | 1.3 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.2 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.1 | 0.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 0.1 | GO:1904351 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.1 | GO:0071046 | nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.1 | 0.4 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 0.2 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.1 | 0.7 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.4 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.1 | 0.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.2 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
0.1 | 0.1 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.1 | 0.4 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 0.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 0.4 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 0.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.6 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.1 | 0.4 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.1 | 0.2 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.1 | 0.2 | GO:0044727 | chromatin reprogramming in the zygote(GO:0044725) DNA demethylation of male pronucleus(GO:0044727) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
0.1 | 0.1 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.2 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.5 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.1 | 0.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.4 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 0.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.1 | 0.3 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.1 | 0.1 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.1 | 0.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.4 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.1 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.5 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.3 | GO:0045872 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.1 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.1 | 0.3 | GO:0003335 | corneocyte development(GO:0003335) |
0.1 | 0.4 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.1 | 0.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.2 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) T-tubule organization(GO:0033292) calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
0.1 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.9 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.1 | 1.1 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.1 | 0.1 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
0.1 | 0.2 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.1 | 0.3 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.1 | 0.5 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.1 | 0.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.1 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 1.4 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.2 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.1 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.5 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.1 | 0.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.2 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.1 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.1 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.1 | 0.1 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.3 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.1 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.1 | 0.1 | GO:0006476 | protein deacetylation(GO:0006476) protein deacylation(GO:0035601) |
0.1 | 0.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 0.2 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.3 | GO:0036343 | psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
0.1 | 1.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.8 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.1 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) positive regulation of androgen receptor activity(GO:2000825) |
0.1 | 0.2 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.1 | 0.4 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.1 | 0.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.1 | 0.4 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 0.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.4 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
0.1 | 0.2 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.2 | GO:1900737 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.1 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.2 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.1 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.5 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.2 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 1.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.2 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.1 | 0.1 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.1 | 0.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.1 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.1 | GO:2000532 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
0.1 | 1.9 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.7 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.6 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.2 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.1 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.1 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.5 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 0.4 | GO:1990834 | response to odorant(GO:1990834) |
0.1 | 0.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.1 | 0.2 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.1 | 0.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 0.3 | GO:1904044 | response to aldosterone(GO:1904044) |
0.1 | 0.3 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.4 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.4 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.1 | 0.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.2 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.1 | 0.2 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.1 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.1 | 0.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.1 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.1 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 0.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.3 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.1 | GO:1900244 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.4 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.1 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.1 | 0.3 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 1.0 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.1 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.2 | GO:0036269 | swimming behavior(GO:0036269) |
0.1 | 0.3 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 1.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.1 | 0.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.1 | 0.1 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 0.4 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.1 | 0.4 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.9 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.9 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.1 | GO:0032899 | regulation of neurotrophin production(GO:0032899) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.3 | GO:0031179 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.1 | 0.2 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 1.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.4 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.2 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.0 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.1 | GO:1990258 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.0 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.9 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.1 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.0 | 0.2 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.0 | 0.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 0.1 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.0 | 0.1 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.0 | 0.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.0 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.0 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) |
0.0 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.0 | 0.2 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 1.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.9 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 1.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.1 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.0 | 0.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.3 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.0 | 0.0 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.7 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.0 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.0 | 0.0 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.0 | 0.8 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.0 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.0 | 0.2 | GO:0001763 | morphogenesis of a branching structure(GO:0001763) |
0.0 | 5.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.1 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.0 | 0.6 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.0 | 0.2 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.0 | 0.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.0 | 0.0 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.0 | 0.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.0 | 0.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.0 | 0.1 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.0 | 0.4 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.2 | GO:0048749 | compound eye development(GO:0048749) |
0.0 | 0.0 | GO:0010665 | regulation of cardiac muscle cell apoptotic process(GO:0010665) |
0.0 | 0.0 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.0 | 0.0 | GO:1990910 | response to hypobaric hypoxia(GO:1990910) |
0.0 | 0.0 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.0 | 0.2 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.0 | 1.8 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric DCT cell differentiation(GO:0072240) |
0.0 | 0.1 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.5 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.6 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 1.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.0 | 0.0 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.0 | 0.2 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.0 | 0.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 1.9 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.0 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.1 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.0 | 1.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0048377 | vacuolar phosphate transport(GO:0007037) lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.0 | 1.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.0 | 0.2 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.1 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.0 | 1.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.0 | 0.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.0 | 0.0 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 0.1 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.0 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.1 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) |
0.0 | 0.2 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.0 | 0.1 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.0 | 0.3 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.0 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.0 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.0 | 0.1 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.0 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.0 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.0 | 0.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.0 | 0.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.2 | GO:2001074 | thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.0 | 0.5 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.0 | 0.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
0.0 | 0.1 | GO:0051029 | rRNA transport(GO:0051029) |
0.0 | 0.0 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.2 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.0 | 0.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.2 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.0 | 0.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.1 | GO:1902943 | regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.0 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.0 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) regulation of positive thymic T cell selection(GO:1902232) |
0.0 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.0 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.0 | 0.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 3.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.3 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.2 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.0 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.0 | 0.1 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.0 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.4 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.2 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.3 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.0 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.0 | 0.2 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.0 | 0.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.0 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.3 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.0 | 0.4 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.2 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.2 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.0 | 0.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.3 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.0 | 0.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 0.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.0 | 0.1 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.0 | 0.0 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.0 | 0.0 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.0 | 0.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.0 | 1.9 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.0 | 0.8 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.1 | GO:1900673 | olefin metabolic process(GO:1900673) |
0.0 | 1.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.5 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.1 | GO:0038194 | thyroid-stimulating hormone signaling pathway(GO:0038194) |
0.0 | 0.2 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) modification by virus of host mRNA processing(GO:0046778) |
0.0 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.2 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.0 | 0.0 | GO:0001656 | metanephros development(GO:0001656) |
0.0 | 0.3 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.0 | 0.1 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.0 | 0.0 | GO:1990637 | response to prolactin(GO:1990637) |
0.0 | 0.2 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.2 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.0 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.5 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.8 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.1 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.3 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.0 | 0.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.0 | 0.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.3 | GO:1900045 | histone H2A K63-linked ubiquitination(GO:0070535) negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.1 | GO:1990828 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
0.0 | 0.1 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.0 | 0.0 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.2 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.0 | 0.1 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.0 | 0.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.3 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.0 | 0.3 | GO:0006452 | translational frameshifting(GO:0006452) peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.0 | 0.1 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.0 | 0.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.1 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.0 | 0.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.0 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.0 | 0.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.0 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.0 | 0.1 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.0 | 0.1 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.0 | 0.0 | GO:2000193 | regulation of icosanoid secretion(GO:0032303) positive regulation of icosanoid secretion(GO:0032305) positive regulation of fatty acid transport(GO:2000193) |
0.0 | 0.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.0 | 0.6 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.2 | GO:0072708 | response to sorbitol(GO:0072708) cellular response to sorbitol(GO:0072709) |
0.0 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.0 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.0 | 0.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.3 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.1 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.8 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.0 | GO:0018199 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.1 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.0 | 0.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.4 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.2 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.0 | 0.3 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.0 | 0.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.2 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.0 | 1.4 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.1 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.0 | 0.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 0.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:0021503 | neural fold bending(GO:0021503) |
0.0 | 0.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.0 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.0 | 0.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.1 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.0 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0090306 | spindle assembly involved in female meiosis(GO:0007056) spindle assembly involved in meiosis(GO:0090306) |
0.0 | 0.1 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.0 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.2 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.1 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.0 | 0.1 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.2 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.0 | 0.2 | GO:0010731 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.0 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.0 | 0.1 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.0 | 0.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.1 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.0 | 0.1 | GO:0098773 | hair follicle development(GO:0001942) skin epidermis development(GO:0098773) |
0.0 | 0.2 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 0.3 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.1 | GO:0044209 | AMP salvage(GO:0044209) |
0.0 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.0 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.0 | 0.1 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.0 | 0.0 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.0 | 0.1 | GO:0070316 | regulation of G0 to G1 transition(GO:0070316) |
0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.0 | 0.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 1.3 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.2 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.0 | 0.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.0 | 0.1 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.2 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.0 | 0.1 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
0.0 | 0.1 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.0 | 0.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.0 | 0.3 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
0.0 | 0.1 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.0 | 0.3 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.0 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.0 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.1 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.1 | GO:1903980 | positive regulation of microglial cell activation(GO:1903980) |
0.0 | 0.1 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.0 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.0 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.0 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
0.0 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.1 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.0 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.0 | 0.1 | GO:0031016 | pancreas development(GO:0031016) |
0.0 | 0.0 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.0 | 0.1 | GO:0050893 | sensory processing(GO:0050893) |
0.0 | 0.0 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.0 | 0.0 | GO:0010193 | response to ozone(GO:0010193) |
0.0 | 0.0 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.0 | 0.0 | GO:0036301 | macrophage colony-stimulating factor production(GO:0036301) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.0 | 0.0 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.1 | GO:0043201 | response to leucine(GO:0043201) |
0.0 | 0.3 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.6 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.1 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.0 | 0.0 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.0 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.3 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.6 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.0 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.0 | 0.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 1.0 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 0.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.1 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.0 | 0.0 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.0 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.2 | GO:1902846 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.0 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.0 | 0.3 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.3 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0031247 | actin rod assembly(GO:0031247) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.2 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.1 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.0 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.4 | GO:0009755 | hormone-mediated signaling pathway(GO:0009755) |
0.0 | 0.0 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.0 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.3 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.2 | GO:0015820 | leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.0 | GO:0048241 | epinephrine transport(GO:0048241) |
0.0 | 0.6 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.1 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.0 | 0.0 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.0 | 0.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.0 | 0.2 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 0.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.0 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.0 | 0.0 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.1 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.3 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) |
0.0 | 0.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.1 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.0 | GO:1903416 | response to glycoside(GO:1903416) |
0.0 | 0.1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.3 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
0.0 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 1.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:0043144 | snoRNA processing(GO:0043144) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.1 | GO:0000423 | macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.2 | GO:0003281 | ventricular septum development(GO:0003281) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) inositol phosphate-mediated signaling(GO:0048016) |
0.0 | 0.2 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.0 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.1 | GO:0061047 | regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.0 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.1 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.0 | 0.0 | GO:0001776 | leukocyte homeostasis(GO:0001776) lymphocyte homeostasis(GO:0002260) |
0.0 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.0 | GO:1902617 | response to fluoride(GO:1902617) |
0.0 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.4 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.2 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 1.2 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.1 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.7 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.0 | 0.0 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.0 | 0.1 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.0 | 0.0 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.1 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.1 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.0 | 0.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.0 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.0 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.0 | 0.3 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.0 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.2 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.0 | 0.0 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.0 | 0.1 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 2.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 0.3 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.0 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.0 | 0.1 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.0 | 0.0 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.0 | 0.0 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.0 | 0.0 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 2.0 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.0 | 0.1 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.0 | 0.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.2 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.1 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.0 | 0.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.4 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.0 | 0.0 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.0 | 0.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 0.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.0 | 0.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.0 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.0 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.1 | GO:1990539 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.0 | 0.2 | GO:0061337 | cardiac conduction(GO:0061337) |
0.0 | 0.1 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.0 | 0.0 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.4 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.0 | 0.1 | GO:2000343 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.0 | 0.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.0 | 0.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.0 | 0.0 | GO:0070895 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
0.0 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.0 | GO:1900223 | negative regulation of beta-amyloid clearance(GO:1900222) positive regulation of beta-amyloid clearance(GO:1900223) |
0.0 | 0.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.2 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) |
0.0 | 0.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.2 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.1 | GO:1901355 | cellular response to rapamycin(GO:0072752) response to rapamycin(GO:1901355) |
0.0 | 0.1 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.0 | 0.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.0 | 0.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.0 | 0.1 | GO:0009386 | translational attenuation(GO:0009386) |
0.0 | 0.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.0 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.0 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.8 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.0 | 0.0 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.0 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.0 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.0 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.1 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.0 | 0.2 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.1 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.0 | 0.0 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.0 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.1 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
0.0 | 0.1 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.2 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.0 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.0 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0044211 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) CTP salvage(GO:0044211) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.0 | GO:0002276 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.0 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 0.0 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.0 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.1 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.0 | 0.1 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.0 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.1 | GO:1903725 | regulation of phospholipid metabolic process(GO:1903725) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.0 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.0 | 0.1 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.1 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.0 | 0.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.0 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.0 | 0.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.0 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.0 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.0 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.0 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.0 | GO:0072497 | mesenchymal stem cell differentiation(GO:0072497) regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.0 | 0.0 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.0 | 0.1 | GO:0001662 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.0 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.0 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.0 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.1 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.0 | 0.0 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.0 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.2 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.0 | 0.1 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.0 | 0.0 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.0 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.0 | 0.1 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.1 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.0 | 0.0 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.0 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.0 | 0.0 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) |
0.0 | 0.0 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
0.0 | 0.0 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 0.1 | GO:0045837 | negative regulation of mitochondrial membrane potential(GO:0010917) negative regulation of membrane potential(GO:0045837) |
0.0 | 0.0 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.0 | 0.1 | GO:0017145 | stem cell division(GO:0017145) |
0.0 | 0.1 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 1.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.0 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.0 | GO:0039019 | pronephric nephron morphogenesis(GO:0039007) pronephric nephron tubule morphogenesis(GO:0039008) pronephric nephron development(GO:0039019) pronephric nephron tubule development(GO:0039020) pronephric duct development(GO:0039022) pronephric duct morphogenesis(GO:0039023) Kupffer's vesicle development(GO:0070121) |
0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0031116 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.0 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.0 | 0.0 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 0.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.0 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.0 | 0.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.0 | GO:1904504 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.0 | 0.0 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.0 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.1 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.0 | 0.1 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 0.0 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.0 | 0.0 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | GO:0044217 | host(GO:0018995) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.4 | 1.3 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.4 | 3.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 3.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.7 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.2 | 1.4 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 1.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.2 | 2.9 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.2 | GO:0000806 | Y chromosome(GO:0000806) |
0.2 | 0.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.2 | 1.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.6 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 1.1 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.2 | 1.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 1.0 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 1.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.1 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.1 | 0.4 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
0.1 | 0.5 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.1 | 0.4 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 0.5 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.7 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 1.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.1 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.1 | 0.7 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 1.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.1 | 0.9 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.3 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 0.1 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.1 | 0.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 0.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.4 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.1 | 0.3 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 0.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 0.4 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.1 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 2.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 1.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 1.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.2 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
0.1 | 2.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.5 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.6 | GO:0014802 | terminal cisterna(GO:0014802) |
0.1 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 3.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.2 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 1.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 0.2 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 0.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.1 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.1 | 0.1 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.1 | 1.3 | GO:0032059 | bleb(GO:0032059) |
0.1 | 5.5 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.5 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.4 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 0.4 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.1 | 1.9 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 0.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.3 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.1 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 3.6 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.2 | GO:0039713 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.1 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.3 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.1 | 0.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 0.1 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.1 | 0.1 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.1 | 0.1 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.9 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 1.0 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.8 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.0 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 0.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.2 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.0 | 0.2 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.0 | 0.0 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.0 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.3 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.0 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.3 | GO:0032044 | DSIF complex(GO:0032044) |
0.0 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.4 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.0 | 1.0 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.2 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.0 | 0.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.0 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.0 | 0.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.3 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.2 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.0 | 0.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 0.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 2.8 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.0 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.0 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.2 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.0 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.0 | 0.1 | GO:0070702 | inner mucus layer(GO:0070702) outer mucus layer(GO:0070703) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.2 | GO:0033643 | host cell part(GO:0033643) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 1.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 1.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.0 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.6 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.1 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.0 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 2.8 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.1 | GO:0031592 | centrosomal corona(GO:0031592) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.0 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.1 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.0 | 0.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.0 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 1.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.6 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.0 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.0 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.1 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.0 | 1.9 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.0 | 0.1 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.4 | GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.0 | 0.5 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.7 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.1 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.0 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 3.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 2.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 3.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.4 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 2.6 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 1.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.2 | GO:0055028 | cortical microtubule(GO:0055028) |
0.0 | 0.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 2.7 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 2.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.3 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 0.1 | GO:0001534 | radial spoke(GO:0001534) |
0.0 | 0.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.0 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.0 | 0.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 1.8 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 2.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 1.9 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.5 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 1.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.0 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.1 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0097196 | Shu complex(GO:0097196) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 2.1 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 1.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 2.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.0 | 0.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.0 | GO:0042025 | host cell nucleus(GO:0042025) |
0.0 | 0.0 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.0 | 0.9 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.2 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.7 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.1 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0097361 | CIA complex(GO:0097361) |
0.0 | 6.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 1.1 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 2.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.0 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.0 | GO:0036019 | endolysosome(GO:0036019) |
0.0 | 0.0 | GO:0035101 | FACT complex(GO:0035101) |
0.0 | 0.9 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.0 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.0 | 0.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.6 | 7.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.5 | 3.2 | GO:0046979 | TAP2 binding(GO:0046979) |
0.3 | 2.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.3 | 0.9 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.3 | 1.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 1.1 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.2 | 0.5 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.2 | 0.9 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.2 | 1.4 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 0.6 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
0.2 | 1.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.2 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 1.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.2 | 0.5 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.2 | 0.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.2 | 0.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.7 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.2 | 0.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.2 | 1.0 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.2 | 0.5 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.2 | 0.6 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.2 | 0.5 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.2 | 1.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 0.5 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.2 | 0.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 2.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.6 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.4 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.4 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.1 | 0.4 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.1 | 0.4 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.1 | 0.1 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 0.4 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.4 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 0.4 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 0.9 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.1 | 0.1 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 1.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.5 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 1.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.4 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 3.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.4 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
0.1 | 0.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.3 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
0.1 | 0.5 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.1 | 0.5 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.1 | 0.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 0.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.4 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.1 | 0.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 0.4 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.1 | 0.3 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.1 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.1 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.1 | 0.4 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.3 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.1 | 0.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.4 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 1.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 1.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.3 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.1 | 0.5 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.1 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.1 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.6 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.1 | 0.1 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 0.4 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 0.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 4.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.8 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.3 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.1 | 0.9 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.6 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.1 | 0.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.9 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.6 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 1.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 1.8 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.3 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.1 | 0.6 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 1.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.2 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
0.1 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.3 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.2 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.1 | 0.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.2 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 1.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 2.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 1.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 0.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 0.3 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.2 | GO:0086039 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.9 | GO:0044877 | macromolecular complex binding(GO:0044877) |
0.1 | 3.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.2 | GO:0032093 | SAM domain binding(GO:0032093) |
0.1 | 0.8 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 1.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 1.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 1.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.2 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.1 | 0.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 1.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.2 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.1 | 0.6 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.2 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 1.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.2 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.2 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 0.8 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 0.2 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.1 | 0.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 0.2 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.1 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.1 | 0.2 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:1903135 | cupric ion binding(GO:1903135) |
0.1 | 0.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.1 | 0.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.2 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.7 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 1.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 1.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 1.9 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 0.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 0.4 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 1.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.1 | GO:0050997 | phosphatidylcholine binding(GO:0031210) quaternary ammonium group binding(GO:0050997) |
0.1 | 0.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 1.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.2 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.1 | 0.3 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 4.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.6 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.1 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.1 | 0.2 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.1 | 0.4 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 1.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.3 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.0 | 0.1 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
0.0 | 1.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.4 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.0 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.1 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.0 | 0.4 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.0 | 0.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.0 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.0 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0099529 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.1 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.0 | 0.2 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.0 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.0 | 0.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 0.0 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.3 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 1.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.0 | GO:0008410 | 3-oxoacid CoA-transferase activity(GO:0008260) CoA-transferase activity(GO:0008410) |
0.0 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 3.0 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 2.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.0 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.2 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.4 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.0 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.0 | 0.3 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.0 | 0.2 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.0 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.1 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.0 | GO:0001156 | RNA polymerase III transcription factor binding(GO:0001025) TFIIIC-class transcription factor binding(GO:0001156) |
0.0 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.0 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.0 | 0.1 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.0 | 0.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 1.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.0 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.0 | 0.2 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.0 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.0 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 1.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.2 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.0 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.4 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.1 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
0.0 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.2 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.0 | 0.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.0 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.0 | 0.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 1.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.8 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.0 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 2.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.2 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.0 | 0.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.0 | 0.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 0.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.0 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 1.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.0 | 0.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.0 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.0 | 0.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.0 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.1 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.0 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 4.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.3 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 1.6 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 2.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.3 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.2 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 0.1 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.0 | 0.1 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.0 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
0.0 | 0.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 3.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.1 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.1 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.0 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.0 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.0 | 1.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 6.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.0 | 0.1 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
0.0 | 0.1 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.1 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.0 | 0.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) UDP-activated nucleotide receptor activity(GO:0045029) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.0 | 0.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.3 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.0 | 0.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 0.2 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.1 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.0 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.0 | 0.0 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.0 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 1.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.2 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.0 | 0.0 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
0.0 | 0.5 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.0 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.0 | 0.1 | GO:0052831 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.0 | 0.1 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0031768 | growth hormone-releasing hormone activity(GO:0016608) ghrelin receptor binding(GO:0031768) |
0.0 | 0.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0016597 | amino acid binding(GO:0016597) |
0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.1 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.0 | 0.1 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.0 | 0.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.0 | 0.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.0 | 0.0 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.0 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.0 | 0.1 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) norepinephrine transmembrane transporter activity(GO:0005333) acetate ester transmembrane transporter activity(GO:1901375) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0031267 | small GTPase binding(GO:0031267) |
0.0 | 0.0 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.5 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.0 | 0.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 0.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.1 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 1.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.0 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0004335 | galactokinase activity(GO:0004335) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) non-sequence-specific DNA binding, bending(GO:0044378) |
0.0 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.4 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.0 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.0 | 0.0 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.0 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.0 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.2 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.0 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.1 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.0 | 0.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.0 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
0.0 | 0.5 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.0 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.0 | 0.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.0 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 0.0 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.2 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.0 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.0 | 0.0 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.1 | GO:1902444 | riboflavin binding(GO:1902444) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.0 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.0 | 1.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 1.1 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 3.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 6.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 2.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 2.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 3.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 2.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 5.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 1.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 1.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 2.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 10.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 2.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 1.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 2.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 20.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 3.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.3 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 2.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.1 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.1 | 1.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 6.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 3.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.4 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 4.7 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.0 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.4 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 1.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 2.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 1.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 3.2 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 2.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 3.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 2.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 1.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.8 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 1.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 1.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 1.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 1.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 4.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.0 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 1.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 1.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 1.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 2.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.8 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |